Dear members of the Canadian Hemophilia Society,

The CHS is interested in your thoughts on novel factor VIII and IX agents that will possibly be introduced in the next few years.  The information and insights you provide will help us to understand patient preferences. We will use this information to advocate for different treatment options. We would greatly appreciate you completing the following questionnaire.  Your answers will remain confidential.

 

Best regards,
David Page
National Executive Director